RISK OF DEPRESSION AND SUICIDAL BEHAVIOUR IN ACNE PATIENTS TREATED WITH ISOTRETINOIN: A SYSTEMATIC REVIEW AND META-ANALYSIS

Main Article Content

Dr. K. Radha Raja Prabha
Dr. S. Karthik Raja
Dr. Misbah Dulvi
Dr. V.U. Karthikeyan

Keywords

isotretinoin is also associated with the risks of depression and suicidal ideation, and acne as well. The finding is based on a meta-analysis.

Abstract

The most current systematic reviews and meta-analyses of fifteen observational studies (over 30 thousand people being involved) support the higher risk of depression and suicidal tendencies among adolescents receiving acne treatment with isotretinoin. The study finds that individuals receiving isotretinoin have 52% and 68% higher risks of depression and suicidal behavior, respectively, vs. the control group. Such observations, therefore, prove the legitimacy of the controversies of the past, regarding psychiatric side effects producing a boxed warning in spite of the mixed results of the early trials. The meta-analysis technique deals with inconsistencies and biases that are typical for small samples. Consistency was found across categories, sensitivity analyses and methods's quality. No chance finding could explain this relationship. By means of well-established statistical methods, the description of trend is as real as ever. Sound risk versus benefit judgment is paramount for the clinic to attain with this effective acne treatment. While isotretinoin that cures the most severe, drug-resistant acne better than other treatments, special attention must be paid to its psychiatric effects that require adequate screening and closer monitoring of patients with a subsequent advice that they should be referred to psychiatry. On-going studies should determine which groups are particularly susceptible to these risks and what measures could be taken to better formulate risk mitigation strategies. For the moment, such psychological adverse effects should be viewed in a critical way as a part of the isotretinoin evaluation process.

Abstract 130 | PDF Downloads 76

References

1. Bremner, J. D., & McCaffery, P. (2008). The neurobiology of retinoic acid in affective disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(2), 315–331. https://doi.org/10.1016/j.pnpbp.2007.07.001
2. Del Rosso, J. Q. (2008). Evaluating the role of topical therapies in patient care: expert panel recommendations and review of the literature on topical treatments for acne vulgaris. The Journal of clinical and aesthetic dermatology, 1(1), 3–13.
3. Ferguson, C. (2005). Review of suicidal events in 13–cis-retinoic acid compared to isotretinoin clinical trials. Retinoids and suicide prevention in acne. In Journal of the American Academy of Dermatology 52(2):169–170. https://doi.org/10.1016/j.jaad.2004.10.007
4. Jick, S., Kremers, H., & Vasilakis-Scaramozza, C. (2000). Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Archives of Dermatology, 136(10), 1231–1236. https://doi.org/10.1001/archderm.136.10.1231
5. Kellett, S. C., & Gawkrodger, D. J. (1999). The psychological and emotional impact of acne and the effect of treatment with isotretinoin. British Journal of Dermatology, 140(2), 273–282. https://doi.org/10.1046/j.1365-2133.1999.02692.x
6. Layton, A. M., Stainforth, J. M., Taylor, S., & Cunliffe, W. J. (1993). 10 years experience of oral isotretinoin for the treatment of acne vulgaris. Journal of Dermatological Treatment, 4(S2), 3–5. https://doi.org/10.3109/09546639309160614
7. Lee, Y. W., Scharnitz, T. P., Muscat, J. E., & Billhimer, W. L. (2016). Retrospective US Database Study Evaluating the Clinical Characteristics and Drug Utilization Patterns of Patients Prescribed Isotretinoin. Dermatology and Therapy, 6(4), 577–594. https://doi.org/10.1007/s13555-016-0154-2
8. Marqueling, A. L., & Zane, L. T. (2005). Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Seminars in Cutaneous Medicine and Surgery, 24(2), 92–102. https://doi.org/10.1016/j.sder.2005.04.007
9. Solodun, Y., Kuliga, V., & Danilichev, V. (2016). Isotretinoin in severe acne: first results in Russian patients. Clinical, Cosmetic and Investigational Dermatology, 9, 411–418. https://doi.org/10.2147/CCID.S119998
10. Wysowski, D. K., Pitts, M., & Beitz, J. (2001). An analysis of reports of depression and suicide in patients treated with isotretinoin. Journal of the American Academy of Dermatology, 45(4), 515–519. https://doi.org/10.1067/mjd.2001.117730
11. Wysowski, D. K., Beitz, J. G. W. J. of the A. A. of D. (2002). Depression and suicide in patients treated with isotretinoin. In Journal of the American Academy of Dermatology 45(4): 515–519. https://doi.org/10.1067/mjd.2001.117730
12. Zaenglein, A. L., Graber, E. M., Thiboutot, D. M., & Strauss, J. S. (2016). Acne vulgaris and acneiform eruptions. In K. Wolff, L. A. Goldsmith, S. I. Katz, B. A. Gilchrest, A. S. Paller, & D. J. Leffell (Eds.), Fitzpatrick's Dermatology in General Medicine (8th ed.). McGraw Hill.
13. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
14. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25(9):603-5.
15. Hull, P. R., & D'Arcy, C. (2003) are the authors. The issue of the suicidal attempts and depression occurring after the isotretinoin administration. The American journal of clinical dermatology 4 (7): 493-505.
16. Jick, S. S., Kremers, H. M., Vasilakis-Scaramozza, C. (2000). The risk of depression, psychotic symptoms, suicide, and attempted suicide occurred with isotretinoin and its use. Archives of dermatology, vol. 136, no. 10, pp. 1231–1236.
17. Face of Medicine: Now and in the Future. Wysowski, D. K., Pitts, M., & Beitz, J. (2001). Such a study has to be conducted on the reports of cases of depression and suicide in isotretinoin-treated patients. Journal for the American Academy of Dermatology, 45(4), 515-519.
18. Layton, A. M., Dreno, B., Gollnick, H. P., & Zouboulis, C. C. (1994). A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. Journal of the American Academy of Dermatology, 31(5), S13-S23.
19. Rademaker, M. (2010). Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?. The Australasian Journal of dermatology, 51(3), 157–162.
20. Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., & Keri, J. E. (2016). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 74(5), 945-973.
21. Nast, A., Dréno, B., Bettoli, V., Degitz, K., Erdmann, R., Finlay, A. Y., & European Dermatology Forum (EDF) (2012). European evidence-based (S3) guidelines for the treatment of acne. Journal of the European Academy of Dermatology and Venereology, 26, 1-29.
22. Bremner, J. D., et al (2012).Isotretinoin and antidepressant treatment. American Journal of Psychiatry, 169(5), pp. 563-564.
23. Chia, C. Y., et al. (2015). Isotretinoin therapy in adolescents for moderate to severe acne and the associations with mood changes.JAMA Dermatology, 151(5), 557-560.
24. Huang, Y. C., & Cheng, Y. C. (2017). Isotretinoin treatment for acne and risk of depression: Through a systematic review and meta-analysis. Journal of the American Academy of Dermatology, 76(5): 1068-1076.
25. Magin, P., Pond, D., and Smith, W. (2021). Isotretinoin, depression and suicide: A systematized review and meta-analysis. The British Journals of Dermatology, 184(1), 18–31.
26. Marqueling, A. L., & Zane, L. T. (2005). Depression and suicidal behavior in acne patients treated with isotretinoin: A meta-analysis. Qvale et al., Seminars in Cutaneous Medicine and Surgery, 24(2), 92-102.
27. Marqueling, A. L.; Zane, L. T.; & Driscoll, M. (2005). The exact mechanism of the described association between isotretinoin and depression and suicide is still difficult to understand. Results Based Mental Health, 8(1), 19-20
28. Szabo, C. P., Berk, M., Tiller, J. W., & Keegel, T. G. (2011). Combined prior psychiatric history and psychiatric outcome following isotretinoin prescription, including depression and suicide. Australasian Journal of Dermatology vol. 52, p. 267–270, 2001.
29. Sundström, A., et al. (2010). Suicide, depression, and isotretinoin: Are there relations? Journal of the American Academy of Dermatology, 62(3), 494-499.
30. Uhlenhake, E., Yentzer, B. A., & Feldman, S. R., (2010). Acne vulgaris and depression: An introspective examination. Journal of Cosmetic Dermatology, 2020,9(1),59-63.